The Young Women's Breast Cancer Study

Summary

The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women consent to the study, they fill-out surveys and give blood samples, and the investigators collect tissue from their breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an additional 7 years (for a total follow-up of at least 10 years following diagnosis). The study investigates short and long-term disease and treatment issues, tumor biology and the relationship to patient outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young women who are newly-diagnosed with breast cancer.

Conditions

• Breast Cancer

Sponsors & Collaborators

• Dana-Farber Cancer Institute

  lead OTHER

Principal Investigators

• Jeffrey Peppercorn, MD · Massachusetts General Hospital

• Steven Come, MD, MPH · Beth Israel Deaconess Medical Center

• Therese Mulvey, MD · Mass General/North-Shore Cancer Center

• Blair Ardman, MD · Lowell General Hospital

• Lawrence Blaszkowsky, MD · Newton-Wellesley Hospital

• Frank G Basile, MD · Cape Cod Hospital

• Ellen Warner, MD · Sunnybrook Health Sciences Centre

• Virginia Borges, MD · University of Colorado, Denver

• Kathryn Ruddy, MD, MPH · Mayo Clinic

• Katherina Zabicki Calvillo, MD, FACS · South Shore Hospital

• Jeanna Walsh, MD · Dana-Farber/New Hampshire Oncology-Hematology

• Natalie Sinclair, MD · DF/BWCC at Milford Regional Medical Center

Eligibility

Min Age

18 Years

Max Age

40 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2006-11-30

Primary Completion

2035-01-31

Completion

2035-01-31

Countries

• United States
• Canada

Study Locations